³Ô¹ÏÍøÕ¾

Latest biotech News | Page 14

AusBiotech 2022 programme features top industry experts
Recruitment open for new study of lung disease
Lumos Diagnostics announces plan to close US facility
New study published demonstrating utility of PromarkerD test
Australia’s Cell and Gene Catalyst moves ahead
Genetic Signatures completes recruitment in pivotal clinical trial
Immuron provides update on FDA review of IND application
Nominations open to recognise sector leaders
Adherium wins US clearance for GSK inhaler users to connect to new platform
Patent filings increase in new intellectual property report
Amplia Therapeutics’ trial to be presented at major US conference
Australia’s first national biotechnology incubator announces round one funding
ACCC clears Pfizer acquisition of Australian digital health company
International consultation on medical device cybersecurity
Collaboration streamlines integration of rich data from medicines access programs to advance cancer treatments
Rhinomed announces Rhinoswab supply deal with SureScreen
Imugene appoints experienced executive as new chief financial officer
Cynata Therapeutics secures US patent for Use of Cymerus MSCs in Asthma
Actinogen confirms Alzheimer’s disease biomarker study timing and design
NeuroScientific Biopharmaceuticals seeks approval for phase 1 trial
ResApp Health extends agreement with Europe’s Medgate
Botanix Pharmaceuticals accelerates filing of NDA
AusBiotech and CSIRO partner to connect sector
CSIRO supports CUREator with funding for health security stream
Dimerix updates with new and positive DMX-700 data
Funding programme increases support for WA researchers
Novotech secures regional ‘Best Biologics CRO’ award
Starpharma’s anti-viral nasal spray relaunched in UK
New leadership for medtech regulatory advisory group
Lumos Diagnostics secures authorisation for test in Canada
Starpharma signs expanded DEP research agreemnent with Genentech
Investment funds support university commercialisation
Victorian government to grant to Hudson Institute for collaboration with Noxopharm
Volpara Health in new collaboration with Microsoft
NSW & QLD Government investments into industry welcomed
New orphan drug designation for Kazia Therapeutics’ paxalisib
Life sciences industry says IP waiver an ’empty shell’ and fact-free decision
High appetite for biotech VC cited in new report
Major software acquisition for leading Australian company ResMed
Registrations are open to ‘come alive’ at AusBiotech 2022
NeuroScientific Biopharmaceuticals reports positive data from animal study
Telix and RefleXion expand partnership for prostate cancer treatment
Regeneus chief executive makes off-market investment in company
Significant growth symbolic of biotech sector’s sovereign value
Dimerix enters agreement for new trial of DMX-200 in diabetic kidney disease
Clarity secures US IND approval for phase 2 prostate cancer trial
Immutep reports positive overall response rate in lung cancer trial
First patient recruited in Dimerix late-stage trial